COVID-19 and AAM - FAQ's and resources from the U.S. generics and biosimilars industry.

Oppose New “Buy American” Restrictions

New “Buy American” requirements on medicines would limit patient access to affordable medicines and increase the risk of drug shortages during the COVID-19 pandemic.

View Fact Sheet
COVID-19 and AAM: FAQs

The coronavirus (COVID-19) pandemic is disrupting everyday life around the world and imposing unprecedented stress on our health care system. Here are some responses and resources from the U.S. generics and biosimilars industry.

Learn More
COVID-19: Ensuring Americans Have Access to Their Medicines

America’s generic and biosimilar manufacturers are committed to meeting the health care needs of patients in the U.S.

Read Blog

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Policy

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Mar 24, 2020 | Rachel Schwartz

AAM Statement: Preserving Patient Access to Low-Cost Medicines Through COVID-19 and Beyond

Buy America Fact Sheet COVID-19

Mar 20, 2020 | Erica Klinger

AAM Buy American Fact Sheet

COVID-19 Response - Patient Access to Medicines

Mar 19, 2020 | Jeff Francer

AAM’s COVID-19 Response: Helping Patients and Families Meet Their Health Care Needs

Mar 18, 2020 | Joseph Stewart

Top 10 Ways to Commemorate the 10th Anniversary of Biosimilars in the U.S.

Coronavirus

Feb 28, 2020 | Jeff Francer

AAM Interim CEO Jeff Francer on COVID-19

Feb 28, 2020 | Erica Klinger

Stories and Data: How AAM Equips Advocates in the States